Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Sullivan

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2004
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, Zhao Zhao, Eugene Lin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2020
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung FibrosisChiara Bellocchi, Jun Ying, Ellen A Goldmuntz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2009
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myelomaCristina Gasparetto, Jon P Gockerman, Louis F Diehl, et al.
Bone Marrow Transplantation|July 7, 2020
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantationKo K Maung, Benny J Chen, Ian Barak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2003
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseasesRichard A Nash, Roger Dansey, Jan Storek, et al.
Arthritis Care & Research|September 17, 2021
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal DataLynette Keyes-Elstein, Ashley Pinckney, Ellen Goldmuntz, et al.
Blood Advances|January 24, 2025
Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation periodAdela R Cardones, Akintunde Emiola, Russell P Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitutionDavid A Rizzieri, Liang Piu Koh, Gwynn D Long, et al.
Plos One|September 11, 2020
Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortalityKo Maung, Sendhilnathan Ramalingam, Mohammad Chaudhry, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2004
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, Zhao Zhao, Eugene Lin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2020
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung FibrosisChiara Bellocchi, Jun Ying, Ellen A Goldmuntz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2009
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myelomaCristina Gasparetto, Jon P Gockerman, Louis F Diehl, et al.
Bone Marrow Transplantation|July 7, 2020
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantationKo K Maung, Benny J Chen, Ian Barak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2003
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseasesRichard A Nash, Roger Dansey, Jan Storek, et al.
Arthritis Care & Research|September 17, 2021
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal DataLynette Keyes-Elstein, Ashley Pinckney, Ellen Goldmuntz, et al.
Blood Advances|January 24, 2025
Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation periodAdela R Cardones, Akintunde Emiola, Russell P Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitutionDavid A Rizzieri, Liang Piu Koh, Gwynn D Long, et al.
Plos One|September 11, 2020
Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortalityKo Maung, Sendhilnathan Ramalingam, Mohammad Chaudhry, et al.
Pageof 10